Pneumococcal meningitis

Pneumococcal meningitis is an inflammation of the membranes of the brain and spinal cord caused by infection with Streptococcus pneumoniae. This pathogen can cause meningitis in both children and adults and leads to serious health consequences, including neurological complications and even death. Pneumococcal meningitis is often the result of pneumococcal infection, which can also manifest as bacteremia, pneumonia, sinusitis, and otitis. The acute nature of the disease, significant mortality, and possible residual effects require rapid and adequate medical intervention.

History of the disease and interesting historical facts

The history of pneumococcal meningitis dates back to the 19th century, when the pneumococcal bacillus was isolated in 1881. The first clinical observations of meningitis caused by this microbe were recorded at the beginning of the 20th century. In 1927, the French scientist E. Cole described the first case associated with pneumococcus. Since then, the disease has attracted the attention of researchers, which has contributed to significant progress in the field of diagnosis and treatment. In recent decades, the development of vaccines against pneumococcus has significantly reduced the incidence of meningitis, however, statistics still indicate the relevance of the problem, especially in high-risk groups.

Epidemiology

Pneumococcal meningitis causes a significant public health burden. According to the World Health Organization, approximately 1.2–2.5 million cases of meningitis caused by Streptococcus pneumoniae are registered annually, including in children under five years of age. Epidemiological studies show that the incidence of pneumococcal meningitis is significantly higher in developing countries where access to health services is limited. However, in industrialized countries, the prevalence of this disease is lower due to the introduction of routine vaccination. The situation is also aggravated by changes in pathogenesis associated with the emergence of resistant strains of pneumococci, which makes the study of this infection extremely relevant.

Genetic predisposition to this disease

To date, some genetic mechanisms predisposing to the development of pneumococcal meningitis have been studied. In particular, some researchers pay attention to mutations in genes associated with the immune response. It is known that incomplete formation of T-cell generations can increase the body's susceptibility to infections, including pneumococcal. It is also worth noting that polymorphisms in genes responsible for the production of cytokines can affect the severity and outcomes of infections caused by Streptococcus pneumoniae. However, definitive cause-and-effect relationships have not yet been established, and further research is needed to understand the complexity of genetic predisposition to this disease.

Risk factors for the development of this disease

There are several risk factors that contribute to the development of pneumococcal meningitis:

• Age: Children under two years of age and older adults are at increased risk.
• Immunodeficiency states: HIV/AIDS, cancer, diabetes, long-term immunosuppressive therapy.
• Recent respiratory tract infection: Pneumonia or sinusitis may precede the development of meningitis.
• Lack of vaccination: The risk is significant for uninitiated children and adults.
• Socioeconomic factors: Low education and income may also increase the risk.

These factors create conditions for increased morbidity and mortality from pneumococcal meningitis, which emphasizes the importance of preventive measures.

Diagnosis of this disease

Diagnosis of pneumococcal meningitis is based on clinical manifestations and laboratory tests. The main symptoms include:

• Headache.
• High body temperature.
• Nausea and vomiting.
• Photophobia.
• Symptoms of meningeal irritation (stiff neck, Kernig's sign).

Laboratory tests include analysis of cerebrospinal fluid obtained by lumbar puncture. The cerebrospinal fluid may show an elevated white blood cell count, increased protein, and decreased glucose. Culture, serology, and molecular biology tests may be used to confirm the diagnosis of pneumococcal meningitis. Radiologic tests such as CT or MRI may be useful to rule out other disorders. A differential diagnosis is needed to rule out other forms of meningitis, such as viral or fungal meningitis, and to determine possible complications.

Treatment

Treatment of pneumococcal meningitis includes both conservative and surgical methods. Conservative therapy is based on the use of antibiotics, primarily third-generation cephalosporins and penicillins. Antibiotic therapy should be started immediately to minimize the risk of complications. Corticosteroids can be used along with antibiotics to reduce the inflammatory response. When necessary, surgery can be performed to remove abscesses or eliminate dropsy.

Clinical monitoring and regular monitoring of the effectiveness of therapy are carried out by repeated CSF analyses and clinical assessment of the patient's condition.

List of medications used to treat this disease

The main antibiotics used to treat pneumococcal meningitis include:

• Cefotaxime.
• Cefriaxone.
• Ampicillin.
• Vancomycin.
• Metronidazole (in certain cases).

Dosage and treatment regimen may vary depending on the clinical situation and tolerance.

Disease monitoring

Monitoring of pneumococcal meningitis includes monitoring the effectiveness of treatment and assessing the dynamics of symptoms. The prognosis of the disease varies, but the fatality rate in untreated cases can be as high as 50%. Residual effects such as cognitive impairment and motor problems are observed in a significant number of patients. Complications can include hydrocephalus, epilepsy, and hearing loss, which emphasizes the importance of prompt treatment and follow-up.

Age-related features of the disease

Pneumococcal meningitis manifests itself differently depending on the age group. In newborns and infants, manifestations may be nonspecific: increased irritability, poor appetite, and temperature changes. In older children, the clinical picture is more pronounced, with classic symptoms of meningitis. In the elderly, the clinical picture may also be erased, which complicates diagnosis. Given age-related features, approaches to treatment and monitoring should be adapted depending on the risk group.

Questions and Answers

• What is pneumococcal meningitis? Pneumococcal meningitis is an inflammation of the membranes lining the brain caused by Streptococcus pneumoniae infection and has a high risk of serious complications.
• What are the main symptoms of pneumococcal meningitis? The main symptoms are headache, high fever, vomiting, photophobia and symptoms of meningeal irritation.
• How is pneumococcal meningitis diagnosed? Diagnosis includes clinical examinations, CSF analysis, laboratory tests, and radiological examinations to confirm the diagnosis.
• What is the treatment for pneumococcal meningitis? Treatment includes antibiotics, corticosteroids, and in some cases surgery to treat complications.
• What is the prognosis for pneumococcal meningitis? Prognosis varies, but untreated meningitis can have a fatality rate of up to 50%, and survivors sometimes have residual effects.